New biomarker for onchocerciasis

A newly identified biomarker detectable in urine could prove useful in developing a portable field test for onchocerciasis or river blindness. Using a painstaking process of metabolomic data mining the researchers were able to identify a metabolite that occurred in the urine from onchocerciasisinfected patients but not in health controls. The metabolite, N-acetyltyramine-O,β-glucuronide, could be traced to O. volvulus as a neurotransmitter molecule that is secreted by young, reproducing worms and then modified by the human body on its way to being excreted in urine. This biomarker appears to be specific for an active infection, suggesting that a field test based on the biomarker would be robustly useful. The next goal would be to create a simple and inexpensive urine dipstick test that is tolerant of extreme temperatures and portable. Current diagnostic methods include biopsies for microscopic analysis, and an ELISA antibody test for microfilariae, which may yield positive results even for non-active infections.
Globisch et al. Proceedings of the National Academy of Sciences, “Onchocerca volvulus Neurotransmitter Tyramine is a Biomarker for River Blindness,†2013 110 (11) 4218-4223.Â
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.